D269-1051 Screening compound: N-{4-[4-(2-methylpropoxy)phenyl]-1,2,5-oxadiazol-3-yl}-4-(propan-2-yloxy)benzamide

D269-1051 Screening compound: N-{4-[4-(2-methylpropoxy)phenyl]-1,2,5-oxadiazol-3-yl}-4-(propan-2-yloxy)benzamide
D269-1051 Screening compound: N-{4-[4-(2-methylpropoxy)phenyl]-1,2,5-oxadiazol-3-yl}-4-(propan-2-yloxy)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D269-1051
N-{4-[4-(2-methylpropoxy)phenyl]-1,2,5-oxadiazol-3-yl}-4-(propan-2-yloxy)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D269-1051

Molecular Formula

C22H25N3O4 (C22 H25 N3 O4)

Compound Name

N-{4-[4-(2-methylpropoxy)phenyl]-1,2,5-oxadiazol-3-yl}-4-(propan-2-yloxy)benzamide

IUPAC name

N-{4-[4-(2-methylpropoxy)phenyl]-125-oxadiazol-3-yl}-4-(propan-2-yloxy)benzamide

SMILES

CC(C)COc(cc1)ccc1-c1nonc1NC(c(cc1)ccc1OC(C)C)=O

InChI

InChI=1S/C22H25N3O4/c1-14(2)13-27-18-9-5-16(6-10-18)20-21(25-29-24-20)23-22(26)17-7-11-19(12-8-17)28-15(3)4/h5-12,14-15H,13H2,1-4H3,(H,23,25,26)

InChI Key

LULLOQCPUGEYSE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD12916177

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

395.46

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.535

Distribution Coefficient, logD

5.485

Water Solubility, LogSw

-5.46

Polar Surface Area

74.388

Acid Dissociation Constant (pKa)

8.32

Base Dissociation Constant (pKb)

-6.59

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.80

D269-1051 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anticancer Library (62698 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with D269-1051 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D269-1051?
Check Price and Availability of D269-1051, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D269-1051 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D269-1051
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D269-1051
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D269-1051 available by request